Blackrock Health Sciences Trust Información sobre dividendos
Blackrock Health Sciences Trust tiene un dividendo anual de 3.15 por acción, con un rendimiento del 7.2743%. El dividendo se paga mensualmente y la última fecha ex-dividendo fue Apr 15, 2026.
Rendimiento de dividendos
Dividendo anual
Fecha de ex-dividendos
7.2743%
$3.15
Apr 15, 2026
Frecuencia de pago
Relación de pago
Mensualmente
65.60%
Historial de dividendos
Fecha de ex-dividendos
Monto en efectivo
Fecha de Registro
Fecha de Pago
Apr 15, 2026
$0.2621
Apr 15, 2026
Apr 30, 2026
Mar 13, 2026
$0.2621
Mar 13, 2026
Mar 31, 2026
Feb 13, 2026
$0.2621
Feb 13, 2026
Feb 27, 2026
Jan 20, 2026
$0.2621
Jan 20, 2026
Jan 30, 2026
Dec 22, 2025
$0.2621
Dec 22, 2025
Dec 31, 2025
Nov 14, 2025
$0.2621
Nov 14, 2025
Nov 28, 2025
Gráficos de dividendos
BME Dividendos
BME Crecimiento de Dividendos (YoY)
Follow-Up Questions
¿Cuál es el dividendo actual pagado por Blackrock Health Sciences Trust y su dividendo anual?
El dividendo actual pagado por Blackrock Health Sciences Trust es de $0.2621. El dividendo anual para Blackrock Health Sciences Trust es de $3.15
¿Cuál es el ratio de pago de dividendos de Blackrock Health Sciences Trust?
El ratio de pago de dividendos para Blackrock Health Sciences Trust es 65.60%
¿Cuál es la fecha ex-dividendo para BME?
La fecha ex-dividendo para Blackrock Health Sciences Trust es Apr 15, 2026.
¿Con qué frecuencia paga dividendos Blackrock Health Sciences Trust?
Trimestral. La última vez que Blackrock Health Sciences Trust pagó un dividendo fue el Apr 30, 2026
Estadísticas clave
Cierre Anterior
$39.07
Precio de apertura
$39.06
Rango del día
$39 - $39.17
Rango de 52 semanas
$34.93 - $42.74
Volumen
15.4K
Volumen promedio
42.2K
Rendimiento de dividendos
7.27%
EPS (TTM)
5.96
Cap. de mercado
$505.4M
¿Qué es BME?
Blackrock Health Sciences Trust is a US-based company operating in industry. The company is headquartered in Wilmington, Delaware. The company went IPO on 2005-03-29. BlackRock Health Sciences Trust (the Trust) is a closed-end management investment company. The Trust investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust seeks to pursue this goal primarily by investing in a portfolio of equity securities and by employing a strategy of writing (selling) call and put options. The Trust invests in a portfolio of sectors, which include pharma, biotech and life sciences; healthcare equipment and services; semiconductors & semiconductor equipment; financial services, and others. BlackRock Advisors, LLC acts as the investment adviser of the Trust.